Study of OTO-104 in Subjects With Unilateral Meniere's Disease

To evaluate the effectiveness of OTO-104 for the treatment of Meniere's Disease.

  1. Tinnitus Talk
    A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease

    Estimated Enrollment: 160
    Actual Study Start Date: October 2015
    Estimated Study Completion Date: July 2017
    Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)
If you have ringing ears then you've come to the right place. We are a friendly tinnitus support board, dedicated to helping you discuss and understand what tinnitus treatments may work for you.